10 new projects will receive funding for identification, development and commercialisation of biomarker tools and technologies.
Innovate UK is pleased to announce the winners of a funding competition to develop new clinical tools for dementia and neurodegeneration. The focus of the competition is on enhancing clinical trials and precision therapies for dementia patients.
It is a significant step towards advancing dementia research and therapy development, and Innovate UK has awarded over £6 million in funding to 10 innovative organisations through its Small Business Research Initiative (SBRI).
The number of people in the UK with dementia is estimated at 850,000. It is a complex and diverse disease, posing challenges in identifying effective treatments for patients.
